160 related articles for article (PubMed ID: 11939269)
1. Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.
Sanda T; Lida S; Ito M; Tsuboi K; Miura K; Harada S; Komatsu H; Wakita A; Inagaki H; Ueda R
Int J Hematol; 2002 Feb; 75(2):195-200. PubMed ID: 11939269
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Kouzaki H; Kitanishi T; Kitano H; Suzuki M
Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
4. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation.
Nagafuji K; Fujisaki T; Arima F; Ohshima K
Int J Hematol; 2001 Dec; 74(4):447-50. PubMed ID: 11794702
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas.
Takenaka K; Shinagawa K; Maeda Y; Makita M; Kozuka T; Ashiba A; Yamamoto K; Fujii N; Nawa Y; Hiramatsu Y; Sunami K; Ishimaru F; Yoshimo T; Kiura K; Harada M
Leuk Lymphoma; 2001; 42(6):1297-303. PubMed ID: 11911411
[TBL] [Abstract][Full Text] [Related]
6. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
8. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
9. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
[TBL] [Abstract][Full Text] [Related]
10. [Nasal NK/T-cell lymphoma: about two rare cases].
Bouayad N; Oubelkacem N; Bono W; Masbah O; Bouhafa T; Elmazghi A; Khalid H
Pan Afr Med J; 2018; 30():141. PubMed ID: 30374387
[TBL] [Abstract][Full Text] [Related]
11. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.
Reimer P; Schertlin T; Rüdiger T; Geissinger E; Roth S; Kunzmann V; Weissinger F; Nerl C; Schmitz N; Müller-Hermelink HK; Wilhelm M
Hematol J; 2004; 5(4):304-11. PubMed ID: 15297846
[TBL] [Abstract][Full Text] [Related]
12. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.
Koizumi K; Fujimoto K; Haseyama Y; Endo T; Nishio M; Yokota K; Itoh T; Sawada K; Koike T
Eur J Haematol; 2004 Feb; 72(2):140-4. PubMed ID: 14962252
[TBL] [Abstract][Full Text] [Related]
13. [Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy].
Tamai Y; Imataki O; Abe Y; Hagiwara S; Ito I; Asakura H; Harada H; Kamata M; Nishimura T; Kawakami K
Gan To Kagaku Ryoho; 2006 May; 33(5):687-90. PubMed ID: 16685174
[TBL] [Abstract][Full Text] [Related]
14. Mediastinal single nodal relapse of a nasal NK/T cell lymphoma.
Rhee KH; Hong SC; An JM; Huh J; Sook RJ; Lee JS; Suh C
Korean J Intern Med; 2007 Sep; 22(3):201-5. PubMed ID: 17939339
[TBL] [Abstract][Full Text] [Related]
15. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
Rodriguez J; Romaguera JE; Manning J; Ordonez N; Ha C; Ravandi F; Cabanillas F
Leuk Lymphoma; 2000 Sep; 39(1-2):139-44. PubMed ID: 10975392
[TBL] [Abstract][Full Text] [Related]
16. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
17. Optimal specimen site for diagnosis of nasal T/NK cell lymphoma and treatment including bone marrow transplantation.
Sakamoto M; Miyairi Y; Ishizawa M
ORL J Otorhinolaryngol Relat Spec; 2003; 65(5):275-8. PubMed ID: 14730183
[TBL] [Abstract][Full Text] [Related]
18. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
19. [CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
Honda S; Ito Y; Otawa M; Katagiri T; Kuriyama Y; Serizawa H; Ebihara Y; Mukai K; Ohyashiki K
Rinsho Ketsueki; 2001 May; 42(5):420-5. PubMed ID: 11452463
[TBL] [Abstract][Full Text] [Related]
20. CD3
Ando Y; Maeshima AM; Fukuhara S; Makita S; Munakata W; Suzuki T; Maruyama D; Taniguchi H; Izutsu K
Int J Hematol; 2018 Sep; 108(3):344-347. PubMed ID: 29572766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
